Zobrazeno 1 - 10
of 395
pro vyhledávání: '"Kevin Winthrop"'
Publikováno v:
ERJ Open Research, Vol 10, Iss 4 (2024)
Background While antibiotics are recommended for treatment of nontuberculous mycobacterial lung disease (NTMLD), the impact of early antibiotic initiation on healthcare resource utilisation is unclear. This study compared healthcare resource utilisat
Externí odkaz:
https://doaj.org/article/bb61454fd06149c9b3b3de32e389852a
Autor:
Isaac R. Cinco, Ethan G. Napier, Nicholas S. Rhoades, Michael H. Davies, Derek B. Allison, Steven G. Kohama, Luiz Bermudez, Kevin Winthrop, Cristina Fuss, Eliot R. Spindel, Ilhem Messaoudi
Publikováno v:
mBio, Vol 15, Iss 6 (2024)
ABSTRACT Nontuberculous mycobacteria (NTM) are environmentally ubiquitous organisms that predominately cause NTM pulmonary disease (NTMPD) in individuals over the age of 65. The incidence of NTMPD has increased in the U.S., exceeding that of Mycobact
Externí odkaz:
https://doaj.org/article/89a22a37f1974bcca987ff07ebaeda52
Autor:
Vivian P. Bykerk, Peter Nash, David Nicholls, Yoshiya Tanaka, Kevin Winthrop, Christina Popova, Nicola Tilt, Derek Haaland
Publikováno v:
Rheumatology and Therapy, Vol 10, Iss 3, Pp 693-706 (2023)
Abstract Introduction There is a paucity of data on how patient characteristics may affect the long-term durability of certolizumab pegol (CZP) in patients with rheumatoid arthritis (RA). This study therefore aimed to investigate CZP durability and r
Externí odkaz:
https://doaj.org/article/9b9eee02ab004b669a8f54f870bb39c3
Autor:
Huda Asif, Franck F. Rahaghi, Akihiro Ohsumi, Julie Philley, Amir Emtiazjoo, Takashi Hirama, Arthur W. Baker, Chin-Chung Shu, Fernanda Silveira, Vincent Poulin, Pete Rizzuto, Miki Nagao, Pierre-Régis Burgel, Steve Hays, Timothy Aksamit, Takeshi Kawasaki, Charles Dela Cruz, Stefano Aliberti, Takahiro Nakajima, Stephen Ruoss, Theodore K. Marras, Gregory I. Snell, Kevin Winthrop, Mehdi Mirsaeidi
Publikováno v:
ERJ Open Research, Vol 9, Iss 2 (2023)
Rationale Nontuberculous mycobacterial (NTM) diseases are difficult-to-treat infections, especially in lung transplant (LTx) candidates. Currently, there is a paucity of recommendations on the management of NTM infections in LTx, focusing on Mycobact
Externí odkaz:
https://doaj.org/article/4c7d713812a8438997c0717e1067401e
Autor:
Jeffrey R. Curtis, Kevin Winthrop, Rhonda L. Bohn, Robert Suruki, Sarah Siegel, Jeffrey L. Stark, Fenglong Xie, Huifeng Yun, Lang Chen, Atul Deodhar
Publikováno v:
ACR Open Rheumatology, Vol 3, Iss 11, Pp 743-752 (2021)
Objective The objective of this study was to investigate the diagnostic prevalence of ankylosing spondylitis (AS) and axial spondyloarthritis (axSpA) in the United States and examine treatment patterns for these diseases. Methods This retrospective o
Externí odkaz:
https://doaj.org/article/cdb27824a955451f8f3fd665c4e5edf8
Autor:
Désirée van der Heijde, Maxime Dougados, Naveed Sattar, Tsutomu Takeuchi, Iain B McInnes, Daniel Aletaha, Tanja A Stamm, Christian Dejaco, Josef S Smolen, Gerd R Burmester, Kevin Winthrop, Michael Trauner, Angelo Ravelli, Andreas Kerschbaumer, Eva Chwala, Kastriot Kastrati, Marieke J H Voshaar
Publikováno v:
RMD Open, Vol 8, Iss 2 (2022)
Objectives Informing an international task force updating the consensus statement on efficacy and safety of biological disease-modifying antirheumatic drugs (bDMARDs) selectively targeting interleukin-6 (IL-6) pathway in the context of immune-mediate
Externí odkaz:
https://doaj.org/article/07c0e01a19cd41a7ac3ac3a49ec670ab
Autor:
Vivian P. Bykerk, Andrew Blauvelt, Jeffrey R. Curtis, Cécile Gaujoux‐Viala, Tore K. Kvien, Kevin Winthrop, Nicola Tilt, Christina Popova, Xavier Mariette, Boulos Haraoui
Publikováno v:
ACR Open Rheumatology, Vol 3, Iss 8, Pp 501-511 (2021)
Objective To investigate the impact of baseline and time‐varying factors on the risk of serious adverse events (SAEs) in patients during long‐term certolizumab pegol (CZP) treatment. Methods Safety data were pooled across 34 CZP clinical trials i
Externí odkaz:
https://doaj.org/article/bc65d43bb8c340d5b0b51aece614f660
Autor:
George M. Solomon, Alan F. Barker, Elizabeth McSpiritt, Sonja Marikovics, Alexandra L. Quittner, Charles Daley, Leigh Anne Daniels, Jodie Jones, Pamela McShane, Alexandra Quittner, Kevin Winthrop, Patricia Walker, Sebastian Kurz, Louis DePalo, Charles Haworth, Richard Belkin, Charles L. Daley, Joseph Khabbaza, Elliott Dasenbrook
Publikováno v:
ATS Scholar. 4:76-86
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c965de647af898655e03e36ae2500c3e
https://doi.org/10.34197/ats-scholar.2022-0061in
https://doi.org/10.34197/ats-scholar.2022-0061in
Autor:
Maxime Dougados, Roy Fleischmann, Louise Falzon, Kevin Winthrop, Andreas Kerschbaumer, Wolf-Henning Boehncke, Klaus Geissler, Thomas Doerner
Publikováno v:
RMD Open, Vol 6, Iss 3 (2020)
Objectives Review of efficacy and safety of Janus kinase (JAK) inhibition in immune-mediated inflammatory diseases (IMIDs).Methods A systematic literature research (SLR) of all publications on JAK inhibitors (JAKi) treatment published until March 201
Externí odkaz:
https://doaj.org/article/d40f9c83ac5b4977926ed9f5c07fcb39
Autor:
Joel M Kremer, Kevin Winthrop, Dimitrios A Pappas, Jeffrey Greenberg, George Reed, LR Harold, Kevin Kane
Publikováno v:
RMD Open, Vol 6, Iss 3 (2020)
Objectives To determine the effect of hydroxychloroquine on the incidence of new respiratory infections in a large registry of rheumatoid arthritis (RA) patients compared with a matched cohort receiving other conventional disease-modifying antirheuma
Externí odkaz:
https://doaj.org/article/e53ae7e20c5e41f4850aaa44db523a92